Provided by Tiger Trade Technology Pte. Ltd.

Avadel Pharmaceuticals plc

21.64
0.0000
Volume:- -
Turnover:- -
Market Cap:2.12B
PE:-7.53K
High:21.64
Open:21.64
Low:21.64
Close:21.64
52wk High:23.57
52wk Low:6.38
Shares:98.15M
Float Shares:80.64M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0029
EPS(LYR):-0.5133
ROE:-0.32%
ROA:-0.34%
PB:21.62
PE(LYR):-42.16

Loading ...

BRIEF-Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market

Reuters
·
Feb 12

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM

Reuters
·
Feb 12

Avadel Pharmaceuticals Shares Delisted from Nasdaq Following Acquisition

Reuters
·
Feb 12

Alkermes Completes Acquisition of Avadel Pharmaceuticals

Reuters
·
Feb 12

Alkermes Plc - Deal Expected to Be Accretive in 2026

THOMSON REUTERS
·
Feb 12

Alkermes Plc Completes Acquisition of Avadel Pharmaceuticals Plc, Accelerating Entry Into Sleep Medicine Market

THOMSON REUTERS
·
Feb 12

Irish Court Approves Avadel Pharmaceuticals Acquisition by Alkermes

Reuters
·
Feb 11

Avadel Pharmaceuticals- Ireland High Court Sets Hearing for Avadel's Scheme on Alkermes for Feb 10, 2026 - SEC Filing

THOMSON REUTERS
·
Jan 20

Irish Court Sets Date to Sanction Avadel Pharmaceuticals Acquisition by Alkermes

Reuters
·
Jan 20

Avadel Shareholders Approve Acquisition by Alkermes

Reuters
·
Jan 13

Avadel Pharmaceuticals Announces That Avadel Shareholders Approve the Proposed Acquisition by Alkermes

THOMSON REUTERS
·
Jan 13

Assessing Avadel Pharmaceuticals (AVDL) Valuation After a Strong 1-Year Share Price Rally

Simply Wall St.
·
Dec 19, 2025

Avadel Pharmaceuticals Completes Enrollment in Phase 3 Trial of LUMRYZ for Idiopathic Hypersomnia

Reuters
·
Dec 18, 2025

Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 Revitalyz™ Trial in Idiopathic Hypersomnia

THOMSON REUTERS
·
Dec 18, 2025

Avadel Pharmaceuticals Plc - Data Expected in Q2 2026

THOMSON REUTERS
·
Dec 18, 2025

HSR Waiting Period Expires for Avadel Pharmaceuticals Acquisition by Alkermes

Reuters
·
Dec 10, 2025

Press Release: Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting

Dow Jones
·
Dec 04, 2025

Avadel Pharmaceuticals Plc - Scheme Meeting and Egm Scheduled for January 12, 2026

THOMSON REUTERS
·
Dec 02, 2025

BUZZ-H Lundbeck steps down from takeover for Avadel, shares rise 3%

Reuters
·
Nov 27, 2025

Jefferies expects Avadel-Alkermes deal to close

TIPRANKS
·
Nov 27, 2025